Mission

At Northern Leaf, we produce bulk pharmaceutical-grade cannabis-based products for medicinal use (CBPMs) for export to international markets.

From our EU-GMP licensed facility in the Channel Island of Jersey, we combine quality and operational excellence, with high volume execution, to deliver a consistent and compliant supply our partners can rely on.

TW Closeup 2026 02 11 171440 bigx

Vision

Our approach addresses one of the biggest structural challenges in the European medical cannabis market: the lack of consistent, scalable, and reliable supply.

Northern Leaf is uniquely positioned to become Europe’s leading producer of bulk high quality medical cannabis flower API at competitive prices, shaping the market through our operational excellence and ethical practices that all stakeholders can trust.

As markets mature, Northern Leaf will strengthen its genetic IP portfolio, informed by science-led practices and proven cultivation metrics, and continue to invest in pharmaceutical and Ag-tech R&D and vertically integrated expansion

Values